Skip to main content

Semax vs Humanin

Both Semax and Humanin are used for neuroprotection. Here's how their evidence, dosing, and regulatory status actually compare.

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

Humanin

Evidence B

Humanin (HN)

A 24-amino-acid mitochondrial-derived peptide with cytoprotective effects across Alzheimer's, diabetes, and atherosclerosis preclinical models. Endogenous levels decline sharply with age.

View full Humanin profile →

Side-by-Side

AttributeSemaxHumanin
Evidence GradeBB
FDA StatusNot FDA-approved in US — approved in Russia for stroke and cognitive disordersNot FDA-approved — mitochondrial-derived peptide research compound
Typical Dose200–600 mcg intranasal, morningResearch range: 0.5–1 mg subcutaneous (rare clinical use)
Clinics Indexed895
Categoriescognitive, neuroprotectionmitochondrial, longevity, neuroprotection

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Key reported benefits — Humanin

  • Cytoprotection
  • Anti-amyloid effects
  • Insulin sensitization

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons